Keywords: update, genentech, antibody, ami, disappoints, preliminary, results

Update - Genentech antibody for AMI disappoints

Article | 20 June 2000

Print This

Preliminary results of a 415-patient Phase II study of Genentech'santi-CD18 antibody have failed to support the efficacy of the drug ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in